Gene · 5916
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia. | EMBO Mol Med | 2023 | 37807875 | PubTator, text mining | PubMed |
| The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug-Drug Interaction in Healthy Participants. | Eur J Drug Metab Pharmacokinet | 2023 | 37804430 | PubTator, text mining | PubMed |
| Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. | Mol Cancer | 2023 | 37803407 | PubTator, text mining | PubMed |
| Predicting regional somatic mutation rates using DNA motifs. | PLoS Comput Biol | 2023 | 37782656 | PubTator, text mining | PubMed |
| Control of Mitochondrial Electron Transport Chain Flux and Apoptosis by Retinoic Acid: Raman Imaging In Vitro Human Bronchial and Lung Cancerous Cells. | Cancers (Basel) | 2023 | 37760504 | PubTator, text mining | PubMed |
| AAV-Mediated Targeting of the Activin A-ACVR1R206H Signaling in Fibrodysplasia Ossificans Progressiva. | Biomolecules | 2023 | 37759764 | PubTator, text mining | PubMed |
| Adamantinomatous craniopharyngioma: evolution in the management. | Childs Nerv Syst | 2023 | 37728836 | PubTator, text mining | PubMed |
| Stromal cells-specific retinoic acid determines parturition timing at single-cell and spatial-temporal resolution. | iScience | 2023 | 37720083 | PubTator, text mining | PubMed |
| Inferring gene regulatory network from single-cell transcriptomes with graph autoencoder model. | PLoS Genet | 2023 | 37703293 | PubTator, text mining | PubMed |
| A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment. | Sci Rep | 2023 | 37689790 | PubTator, text mining | PubMed |
| In Vitro Embryogenesis and Gastrulation Using Stem Cells in Mice and Humans. | Int J Mol Sci | 2023 | 37686459 | PubTator, text mining | PubMed |
| Uncovering the role of FOXA2 in the Development of Human Serotonin Neurons. | Adv Sci (Weinh) | 2023 | 37679064 | PubTator, text mining | PubMed |
| Editorial: Case reports in hematological malignancies: 2022. | Front Oncol | 2023 | 37671065 | PubTator, text mining | PubMed |
| Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. | Stem Cell Reports | 2023 | 37657447 | PubTator, text mining | PubMed |
| Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. | Front Cell Dev Biol | 2023 | 37645246 | PubTator, text mining | PubMed |
| Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva. | Pediatr Rheumatol Online J | 2023 | 37644581 | PubTator, text mining | PubMed |
| Genetic analysis of potential biomarkers and therapeutic targets in neuroinflammation from sporadic Creutzfeldt-Jakob disease. | Sci Rep | 2023 | 37644077 | PubTator, text mining | PubMed |
| One-Pot Formal Carboradiofluorination of Alkenes: A Toolkit for Positron Emission Tomography Imaging Probe Development. | J Am Chem Soc | 2023 | 37625118 | PubTator, text mining | PubMed |
| Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies. | PLoS One | 2023 | 37616260 | PubTator, text mining | PubMed |
| Natural Retinol Analogs Potentiate the Effects of Retinal on Aged and Photodamaged Skin: Results from In Vitro to Clinical Studies. | Dermatol Ther (Heidelb) | 2023 | 37615835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5916/papers?page=8